Sanger Sequencing Service Industry Research Report 2025

Summary

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

According to APO Research, The global Sanger Sequencing Service market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Sanger Sequencing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sanger Sequencing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Sanger Sequencing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Sanger Sequencing Service include Source BioScience, GenScript, Thermofisher, Nucleics, GenHunter Corporation, LGC Limited, SciGenom Labs, Fasteris SA and CeMIA SA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sanger Sequencing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sanger Sequencing Service.

The Sanger Sequencing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sanger Sequencing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Sanger Sequencing Service Segment by Company

Source BioScience
GenScript
Thermofisher
Nucleics
GenHunter Corporation
LGC Limited
SciGenom Labs
Fasteris SA
CeMIA SA
Microsynth AG
QuintaraBio
Eurofins
Genewiz

Sanger Sequencing Service Segment by Type

Plasmid DNA
PCR Amplicons
Others

Sanger Sequencing Service Segment by Application

Bioscience Companies
Hospitals
Institutions

Sanger Sequencing Service Segment by Application

Bioscience Companies
Hospitals
Institutions

Sanger Sequencing Service Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sanger Sequencing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Sanger Sequencing Service by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Plasmid DNA
2.2.3 PCR Amplicons
2.2.4 Others
2.3 Sanger Sequencing Service by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Bioscience Companies
2.3.3 Hospitals
2.3.4 Institutions
2.4 Assumptions and Limitations
3 Sanger Sequencing Service Breakdown Data by Type
3.1 Global Sanger Sequencing Service Historic Market Size by Type (2020-2025)
3.2 Global Sanger Sequencing Service Forecasted Market Size by Type (2026-2031)
4 Sanger Sequencing Service Breakdown Data by Application
4.1 Global Sanger Sequencing Service Historic Market Size by Application (2020-2025)
4.2 Global Sanger Sequencing Service Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Sanger Sequencing Service Market Perspective (2020-2031)
5.2 Global Sanger Sequencing Service Growth Trends by Region
5.2.1 Global Sanger Sequencing Service Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Sanger Sequencing Service Historic Market Size by Region (2020-2025)
5.2.3 Sanger Sequencing Service Forecasted Market Size by Region (2026-2031)
5.3 Sanger Sequencing Service Market Dynamics
5.3.1 Sanger Sequencing Service Industry Trends
5.3.2 Sanger Sequencing Service Market Drivers
5.3.3 Sanger Sequencing Service Market Challenges
5.3.4 Sanger Sequencing Service Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Sanger Sequencing Service Players by Revenue
6.1.1 Global Top Sanger Sequencing Service Players by Revenue (2020-2025)
6.1.2 Global Sanger Sequencing Service Revenue Market Share by Players (2020-2025)
6.2 Global Sanger Sequencing Service Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Sanger Sequencing Service Head Office and Area Served
6.4 Global Sanger Sequencing Service Players, Product Type & Application
6.5 Global Sanger Sequencing Service Manufacturers Established Date
6.6 Global Sanger Sequencing Service Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Sanger Sequencing Service Market Size (2020-2031)
7.2 North America Sanger Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Sanger Sequencing Service Market Size by Country (2020-2025)
7.4 North America Sanger Sequencing Service Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Sanger Sequencing Service Market Size (2020-2031)
8.2 Europe Sanger Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Sanger Sequencing Service Market Size by Country (2020-2025)
8.4 Europe Sanger Sequencing Service Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Sanger Sequencing Service Market Size (2020-2031)
9.2 Asia-Pacific Sanger Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Sanger Sequencing Service Market Size by Country (2020-2025)
9.4 Asia-Pacific Sanger Sequencing Service Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Sanger Sequencing Service Market Size (2020-2031)
10.2 South America Sanger Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Sanger Sequencing Service Market Size by Country (2020-2025)
10.4 South America Sanger Sequencing Service Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Sanger Sequencing Service Market Size (2020-2031)
11.2 Middle East & Africa Sanger Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Sanger Sequencing Service Market Size by Country (2020-2025)
11.4 Middle East & Africa Sanger Sequencing Service Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Source BioScience
12.1.1 Source BioScience Company Information
12.1.2 Source BioScience Business Overview
12.1.3 Source BioScience Revenue in Sanger Sequencing Service Business (2020-2025)
12.1.4 Source BioScience Sanger Sequencing Service Product Portfolio
12.1.5 Source BioScience Recent Developments
12.2 GenScript
12.2.1 GenScript Company Information
12.2.2 GenScript Business Overview
12.2.3 GenScript Revenue in Sanger Sequencing Service Business (2020-2025)
12.2.4 GenScript Sanger Sequencing Service Product Portfolio
12.2.5 GenScript Recent Developments
12.3 Thermofisher
12.3.1 Thermofisher Company Information
12.3.2 Thermofisher Business Overview
12.3.3 Thermofisher Revenue in Sanger Sequencing Service Business (2020-2025)
12.3.4 Thermofisher Sanger Sequencing Service Product Portfolio
12.3.5 Thermofisher Recent Developments
12.4 Nucleics
12.4.1 Nucleics Company Information
12.4.2 Nucleics Business Overview
12.4.3 Nucleics Revenue in Sanger Sequencing Service Business (2020-2025)
12.4.4 Nucleics Sanger Sequencing Service Product Portfolio
12.4.5 Nucleics Recent Developments
12.5 GenHunter Corporation
12.5.1 GenHunter Corporation Company Information
12.5.2 GenHunter Corporation Business Overview
12.5.3 GenHunter Corporation Revenue in Sanger Sequencing Service Business (2020-2025)
12.5.4 GenHunter Corporation Sanger Sequencing Service Product Portfolio
12.5.5 GenHunter Corporation Recent Developments
12.6 LGC Limited
12.6.1 LGC Limited Company Information
12.6.2 LGC Limited Business Overview
12.6.3 LGC Limited Revenue in Sanger Sequencing Service Business (2020-2025)
12.6.4 LGC Limited Sanger Sequencing Service Product Portfolio
12.6.5 LGC Limited Recent Developments
12.7 SciGenom Labs
12.7.1 SciGenom Labs Company Information
12.7.2 SciGenom Labs Business Overview
12.7.3 SciGenom Labs Revenue in Sanger Sequencing Service Business (2020-2025)
12.7.4 SciGenom Labs Sanger Sequencing Service Product Portfolio
12.7.5 SciGenom Labs Recent Developments
12.8 Fasteris SA
12.8.1 Fasteris SA Company Information
12.8.2 Fasteris SA Business Overview
12.8.3 Fasteris SA Revenue in Sanger Sequencing Service Business (2020-2025)
12.8.4 Fasteris SA Sanger Sequencing Service Product Portfolio
12.8.5 Fasteris SA Recent Developments
12.9 CeMIA SA
12.9.1 CeMIA SA Company Information
12.9.2 CeMIA SA Business Overview
12.9.3 CeMIA SA Revenue in Sanger Sequencing Service Business (2020-2025)
12.9.4 CeMIA SA Sanger Sequencing Service Product Portfolio
12.9.5 CeMIA SA Recent Developments
12.10 Microsynth AG
12.10.1 Microsynth AG Company Information
12.10.2 Microsynth AG Business Overview
12.10.3 Microsynth AG Revenue in Sanger Sequencing Service Business (2020-2025)
12.10.4 Microsynth AG Sanger Sequencing Service Product Portfolio
12.10.5 Microsynth AG Recent Developments
12.11 QuintaraBio
12.11.1 QuintaraBio Company Information
12.11.2 QuintaraBio Business Overview
12.11.3 QuintaraBio Revenue in Sanger Sequencing Service Business (2020-2025)
12.11.4 QuintaraBio Sanger Sequencing Service Product Portfolio
12.11.5 QuintaraBio Recent Developments
12.12 Eurofins
12.12.1 Eurofins Company Information
12.12.2 Eurofins Business Overview
12.12.3 Eurofins Revenue in Sanger Sequencing Service Business (2020-2025)
12.12.4 Eurofins Sanger Sequencing Service Product Portfolio
12.12.5 Eurofins Recent Developments
12.13 Genewiz
12.13.1 Genewiz Company Information
12.13.2 Genewiz Business Overview
12.13.3 Genewiz Revenue in Sanger Sequencing Service Business (2020-2025)
12.13.4 Genewiz Sanger Sequencing Service Product Portfolio
12.13.5 Genewiz Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings